GlassScriptPhysician profile
Joseph Cohen
NPI 1700815206
$1,906.49
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $867 · 2020: $481 · 2021: $475 · 2023: $83.52.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $83.52.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $83.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $345.07 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $286.81 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $216.88 | 2019-2021 | |
| Amarin Pharma, INC. | $149.07 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $138.83 | 2019-2021 | |
| Abbott Laboratories | $103.53 | 2020-2023 | Amplatzer Amulet |
| Pfizer INC. | $89.86 | 2019-2021 | |
| Amgen INC. | $82.86 | 2019-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $75.91 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $59.11 | 2019 | |
| Merck Sharp & Dohme LLC | $55.69 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $51.71 | 2019-2021 | |
| Arbor Pharmaceuticals, INC. | $38.52 | 2019 | |
| Novo Nordisk INC | $33.72 | 2021 | |
| Braemar Manufacturing, LLC | $33.50 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $26.99 | 2021 | |
| Boston Scientific Corporation | $17.80 | 2020 | |
| Portola Pharmaceuticals, LLC | $17.52 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.85 | 2021 | |
| Sanofi-Aventis U.S. LLC | $14.79 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.44 | 2020 | |
| Elutia, INC. | $13.34 | 2021 | |
| Ge Healthcare | $12.11 | 2021 | |
| Astellas Pharma US INC | $11.58 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Cohen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.